Stay Ahead with the Latest Information Subscribers will receive data updates after each financial quarter for one year, totaling four updates (Q4 2024, Q1 2025, Q2 2025, Q3 2025). These updates are provided in an Excel spreadsheet, making them easily accessible for your marketing, business development, product management teams, and company executives.

With this data, your company will always have the most current information on the size and growth of the molecular diagnostics market. Each update also includes insights on how fluctuations in major global currencies have impacted real growth in the examined markets. Corporate leadership can use the Datastream to guide quarterly market share assessments and measure your company’s growth against the industry.

Quarterly Market Estimates Include:

• Molecular Infectious Disease (Respiratory, Hepatitis, HIV, HAIs/Sepsis, STI, TB, and Other Infections)
• Molecular Oncology (Molecular Assays including CDx and Molecular Histology)
• Molecular Genetic Testing (Inherited Diseases and NIPT)
• Molecular Transplantation
• Molecular NAT Blood Banking Tests
• Molecular Point of Care Tests
• Molecular COVID Testing

This comprehensive data ensures your company remains informed and competitive in the dynamic molecular diagnostics market.